Cargando…
Maintenance of stemness is associated with the interation of LRP6 and heparin-binding protein CCN2 autocrined by hepatocellular carcinoma
BACKGROUND: The overall response rate of hepatocellular carcinoma (HCC) to chemotherapy is poor. In our previous study, oxaliplatin-resistant HCC is found to exhibit an enhanced stemness, and increased levels of CCN2 and LRP6, while the role of CCN2 and LRP6 in the prognosis of HCC patients, and the...
Autores principales: | Jia, Qingan, Bu, Yang, Wang, Zhiming, Chen, Bendong, Zhang, Qiangbo, Yu, Songning, Liu, Qingguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584530/ https://www.ncbi.nlm.nih.gov/pubmed/28870205 http://dx.doi.org/10.1186/s13046-017-0576-3 |
Ejemplares similares
-
CCN3 is a therapeutic target relating enhanced stemness and coagulation in hepatocellular carcinoma
por: Jia, Qingan, et al.
Publicado: (2017) -
Inositol hexaphosphate sensitizes hepatocellular carcinoma to oxaliplatin relating inhibition of CCN2-LRP6-β-catenin-ABCG1 signaling pathway
por: Liao, Xia, et al.
Publicado: (2021) -
Maintenance of Stemness in Oxaliplatin-Resistant Hepatocellular Carcinoma Is Associated with Increased Autocrine of IGF1
por: Bu, Yang, et al.
Publicado: (2014) -
CCN: core regulatory proteins in the microenvironment that affect the metastasis of hepatocellular carcinoma?
por: Jia, Qingan, et al.
Publicado: (2015) -
CCN2–MAPK–Id-1 loop feedback amplification is involved in maintaining stemness in oxaliplatin-resistant hepatocellular carcinoma
por: Liao, Xia, et al.
Publicado: (2019)